Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Current Signal: SELL (auto-tracking)
0.00% $1.840
America/New_York / 24 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 1 424.21 mill |
EPS: | -0.440 |
P/E: | -4.18 |
Earnings Date: | Jul 23, 2024 |
SharesOutstanding: | 774.03 mill |
Avg Daily Volume: | 29.66 mill |
RATING 2024-04-24 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -4.18 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.09x |
Company: PE -4.18 | industry: PE 47.78 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 1.632 - 2.05 ( +/- 11.30%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-19 | Persofsky Renah | Sell | 129 534 | Restricted Stock Units |
2024-01-17 | Faltischek Denise M | Buy | 10 000 | Common Stock |
2024-01-16 | Gendel Mitchell | Buy | 7 200 | Common Stock |
2024-01-12 | Gendel Mitchell | Buy | 5 400 | Common Stock |
2024-01-12 | Simon Irwin D | Buy | 53 700 | Common Stock |
INSIDER POWER |
---|
50.79 |
Last 100 transactions |
Buy: 14 516 538 | Sell: 4 837 023 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $1.840 (0.00% ) |
Volume | 17.67 mill |
Avg. Vol. | 29.66 mill |
% of Avg. Vol | 59.58 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $1.885 | N/A | Active |
---|
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Date | Signal | @ |
---|---|---|
BWLPG.OL | Apr 25 - 07:09 | NOK152.20 |
SADG.OL | Apr 25 - 06:23 | NOK97.11 |
SRBNK.OL | Apr 25 - 07:06 | NOK130.60 |
AKRBP.OL | Apr 25 - 07:05 | NOK283.50 |
ENSU.OL | Apr 25 - 07:04 | 1.326 |
WHITEUSD | Apr 25 - 07:13 | 5 337.33 |
TEL.OL | Apr 25 - 07:02 | NOK126.20 |
SDRL.OL | Apr 25 - 07:02 | 548.00 |
CADLR.OL | Apr 25 - 07:02 | NOK51.60 |
^N100 | Apr 25 - 07:03 | PTS1 507.42 |